The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
Open accessAbstract
BACKGROUND: Vasopressin is commonly used as an adjunct to catecholamines to support blood pressure in refractory septic shock, but its effect on mortality is unknown. We hypothesized that low-dose vasopressin as compared with norepinephrine would decrease mortality among patients with septic shock who were being treated with conventional (catecholamine) vasopressors. METHODS: In this multicenter, randomized, double-blind trial, we assigned patients who had septic shock and were receiving a minimum of 5 microg of norepinephrine per minute to receive either low-dose vasopressin (0.01 to 0.03 U per minute) or norepinephrine (5 to 15 microg per minute) in addition to open-label vasopressors. All vasopressor infusions were titrated and tapered according to protocols to maintain a target blood pressure. The primary end point was the mortality rate 28 days after the start of infusions. RESULTS: A total of 778 patients underwent randomization, were infused with the study drug (396 patients received vasopressin, and 382 norepinephrine), and were included in the analysis. There was no significant difference between the vasopressin and norepinephrine groups in the 28-day mortality rate (35.4% and 39.3%, respectively; P=0.26) or in 90-day mortality (43.9% and 49.6%, respectively; P=0.11). There were no significant differences in the overall rates of serious adverse events (10.3% and 10.5%, respectively; P=1.00). In the prospectively defined stratum of less severe septic shock, the mortality rate was lower in the vasopressin group than in the norepinephrine group at 28 days (26.5% vs. 35.7%, P=0.05); in the stratum of more severe septic shock, there was no significant difference in 28-day mortality (44.0% and 42.5%, respectively; P=0.76). A test for heterogeneity between these two study strata was not significant (P=0.10). CONCLUSIONS: Low-dose vasopressin did not reduce mortality rates as compared with norepinephrine among patients with septic shock who were treated with catecholamine vasopressors. (Current Controlled Trials number, ISRCTN94845869 [controlled-trials.com].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Given the lack of definitive and generalizable data regarding the optimal duration of therapy for patients who are critically ill, it is not surprising that there is considerably practice variation (281,294).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [281]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Restricting antimicrobial therapy to the shortest course associated with better outcomes is an important part of antimicrobial stewardship (281-285).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [281]
Experimental — accuracy not yet measuredIn the citing paper
“in a subgroup analysis, patients with less severe shock receiving norepinephrine < 15 μg/min had improved survival with the addition of vasopressin (26.5% vs. 35.7%, p = 0.05).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [356]
In the citing paper
“the main study (the VASST trial) comparing norepinephrine alone to norepinephrine plus vasopressin (0.01–0.03 U/min) showed no improvement in 28-day mortality (39.3% vs 35.4%, p = 0.26) [356].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [356]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 15,518
APACHE II-A Severity of Disease Classification System
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,379
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference
(1992) · Critical Care Medicine · doi:10.1097/00003246-199206000-00025 · Cited by 5,134
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,309
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea‐Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000117317.18092.e4 · Cited by 3,038
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients
Hayes, M., Timmins, A. C., Yau, E. H. S., Palazzo, M. G. A., Hinds, C., & Watson, D. I. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406163302404 · Cited by 1,530
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
The Pathogenesis of Vasodilatory Shock
Landry, D. W., & Oliver, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002709 · Cited by 1,144
Vasopressin Deficiency Contributes to the Vasodilation of Septic Shock
Landry, D. W., Levin, H. R., Gallant, E. M., Ashton, R. C., Seo, S., D'Alessandro, D., Oz, M. C., & Oliver, J. A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1122 · Cited by 990
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Fergusson, D., Aaron, S. D., Guyatt, G., & Hébert, P. (2002) · BMJ · doi:10.1136/bmj.325.7365.652 · Cited by 708
Self-citationBeneficial Effects of Short-term Vasopressin Infusion during Severe Septic Shock
Patel, B., Chittock, D. R., Russell, J. A., & Walley, K. R. (2002) · Anesthesiology · doi:10.1097/00000542-200203000-00011 · Cited by 677
Self-citationCurrent Epidemiology of Septic Shock
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 657
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620
Self-citationHas the mortality of septic shock changed with time?
Friedman, G., Silva, E., & Vincent, J. (1998) · Critical Care Medicine · doi:10.1097/00003246-199812000-00045 · Cited by 597
The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series
Holmes, C. L., Walley, K. R., Chittock, D. R., Lehman, T., & Russell, J. A. (2001) · Intensive Care Medicine · doi:10.1007/s001340101014 · Cited by 573
Self-citationArginine Vasopressin in Advanced Vasodilatory Shock
Dünser, M. W., Mayr, A. J., Ulmer, H., Knotzer, H., Sumann, G., Pajk, W., Friesenecker, B. E., & Hasibeder, W. R. (2003) · Circulation · doi:10.1161/01.cir.0000066692.71008.bb · Cited by 523
A Trial of Antioxidants N-acetylcysteine and Procysteine in ARDS
Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., & Wright, P. E. (1997) · CHEST Journal · doi:10.1378/chest.112.1.164 · Cited by 429
Self-citationArgenziano, M., Chen, J. M., Choudhri, A. F., Cullinane, S., Garfein, E. S., Weinberg, A. D., Smith, C. R., Rose, E. A., Landry, D. W., & Oz, M. C. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70049-2 · Cited by 394
Vasopressin pressor hypersensitivity in vasodilatory septic shock
Landry, D. W., Levin, H. R., Gallant, E. M., Seo, S. K., D’Alessandro, D. A., Oz, M. C., & Oliver, J. A. (1997) · Critical Care Medicine · doi:10.1097/00003246-199708000-00012 · Cited by 389
Low-Dose Vasopressin in the Treatment of Vasodilatory Septic Shock
Malay, M. B., Ashton, R. C., Landry, D. W., & Townsend, R. N. (1999) · doi:10.1097/00005373-199910000-00014 · Cited by 388
Arginine vasopressin in 316 patients with advanced vasodilatory shock*
Luckner, G., Dünser, M. W., Jochberger, S., Mayr, V. D., Wenzel, V., Ulmer, H., Schmid, S. W., Knotzer, H., Pajk, W., Hasibeder, W. R., et al. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186749.34028.40 · Cited by 316
Dünser, M. W., Mayr, A. J., Tür, A., Pajk, W., Barbara, F., Knotzer, H., Ulmer, H., & Hasibeder, W. R. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000059722.94182.79 · Cited by 250
Intravenous Arginine-Vasopressin in Children With Vasodilatory Shock After Cardiac Surgery
Rosenzweig, E. B., Starc, T. J., Chen, J. M., Cullinane, S., Timchak, D. M., Gersony, W. M., Landry, D. W., & Galantowicz, M. (1999) · Circulation · doi:10.1161/01.cir.100.suppl_2.ii-182 · Cited by 243
High-dose vasopressin is not superior to norepinephrine in septic shock*
Klinzing, S., Simon, M., Reinhart, K., Bredle, D. L., & Meier‐Hellmann, A. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000094260.05266.f4 · Cited by 216
Argenziano, M., Choudhri, A. F., Öz, M. C., Rose, E. A., Smith, C. R., & Landry, D. W. (1997) · PubMed · Cited by 211
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock
Morales, D. L. S., Gregg, D., Helman, D. N., Williams, M. R., Naka, Y., Landry, D. W., & Öz, M. C. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)01197-2 · Cited by 164
The Effect of Vasopressin on Gastric Perfusion in Catecholamine-Dependent Patients in Septic Shock
van Haren, F. M. P., Rozendaal, F. W., & van der Hoeven, J. G. (2003) · CHEST Journal · doi:10.1378/chest.124.6.2256 · Cited by 163
Vasopressin Deficiency and Pressor Hypersensitivity In Hemodynamically Unstable Organ Donors
Chen, J. M., Cullinane, S., Spanier, T. B., Artrip, J. H., John, R., Edwards, N. M., Öz, M. C., & Landry, D. W. (1999) · Circulation · doi:10.1161/01.cir.100.suppl_2.ii-244 · Cited by 146
Symmetrical peripheral gangrene: association with noradrenaline administration
Hayes, M., Yau, E. H. S., Hinds, C., & Watson, J. (1992) · Intensive Care Medicine · doi:10.1007/bf01694349 · Cited by 106
Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation
Argenziano, M., Chen, J. M., Cullinane, S., Choudhri, A. F., Rose, E. A., Smith, C. R., Edwards, N. M., Landry, D. W., & Oz, M. C. (1999) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00038-8 · Cited by 80
Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure
Gold, J. A., Cullinane, S., Chen, J., Seo, S. K., Öz, M. C., Oliver, J. A., & Landry, D. W. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00783-3 · Cited by 70
Renovascular resistance and noradrenaline
Bomzon, L., & Rosendorff, C. (1975) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1975.229.6.1649 · Cited by 25
Research works printed but not linked: 2
- Argenziano M, 1997, Circulation, 96, II
- Chen JM, 1999, Circulation, 100, II
Cited by
Sorted by citations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,371
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationSurviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Self-citation
Metadata
- Authors
- Russell, J. A., Walley, K. R., Singer, J., Gordon, A. C., Hébert, P. C., Cooper, D. J., Holmes, C. L., Mehta, S., Granton, J. T., Storms, M. M., Cook, D. J., Presneill, J. J., & Ayers, D.
- Affiliations
- St. Paul's Hospital (CA)
- University of Ottawa (CA)
- The Alfred Hospital (AU)
- University of British Columbia (CA)
- Mount Sinai Hospital (CA)
- University of Toronto (CA)
- McMaster University (CA)
- The Royal Melbourne Hospital (AU)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-02-28
- Volume
- 358
- Issue
- 9
- Pages
- 877-887
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2108153775
- Cited by
- 1,924
- References
- 36
- Citations by year
- 2026: 106 · 2025: 119 · 2024: 101 · 2023: 91 · 2022: 88 · 2021: 85 · 2020: 104 · 2019: 205 · 2018: 114 · 2017: 104 · 2016: 100 · 2015: 83 · 2014: 91 · 2013: 84 · 2012: 89
- FWCI
- 88.86
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Surgery › Abdominal Surgery and Complications
- Keywords
- septic shock, vasopressin, norepinephrine, vasopressor therapy, catecholamines, mortality, 28-day mortality, 90-day mortality, sepsis treatment, blood pressure support, adverse events, subgroup analysis
- MeSH terms
- Adult, Aged, Blood Pressure, Catecholamines, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Infusions, Intravenous, Male, Middle Aged, Norepinephrine, Severity of Illness Index, Shock, Septic, Vasoconstrictor Agents, Vasopressins, Treatment Failure, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
